BioSpace News Archive

Acclaro Corporation, breaks new ground in medical devices for aesthetics with their revolutionary UltraClear™ system.

Eli Lilly and Company announced its financial results for the first quarter of 2022.

Centogene N.V. announced it has extended its partnership with Takeda to diagnose patients with rare metabolic and rare neurodegenerative diseases.

BitNile Holdings, Inc., a diversified holding company announced its wholly owned subsidiary, Digital Power Lending, LLC has made an additional investment in Alzamend Neuro, Inc., a related party and early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders.

Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical company advancing today’s therapies to enable healthier lives, today presents positive results from the Phase I clinical trial of its ultra-rapid acting, ultra-concentrated insulin product candidate, AT278, at the 15th International Advanced Technologies and Treatments for Diabetes (ATTD) meeting.

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced that Jessica Morris, Chief Operating Officer of Tonix Pharmaceuticals, will present at the 2022 Q2 Investor Summit on Wednesday, May 4, 2022, at 11:00 a.m. ET at the Westin New York Grand Central, New York, NY.

Microbix Biosystems Inc. announces it will be attending and presenting at the Bloom Burton & Co. Healthcare Investor Conference taking place at the Metro Toronto Convention Centre, North Building, in Toronto, Ontario, Canada on May 2nd and 3rd, 2022.

Rapid Therapeutics Science Laboratories (OTC: RTSL) (“Rapid Therapeutic’’ or the “Company”), a growth-oriented aerosol manufacturing company focused on natural relief innovations through trusted aerosol delivery, announces today that its senior management and senior scientists have been invited to attend the Respiratory Drug Delivery (RDD) 2022 Conference.

BeyondSpring Inc. announced three poster presentations relating to lead asset plinabulin at the American Society of Clinical Oncology Annual Meeting being held June 3-7, 2022, in Chicago, Illinois and virtually.

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it will report first quarter 2022 financial results on Thursday, May 5, 2022.